6505-00-138-7347 Bupivacaine hydrochloride inject
One item DLA buys: its open requests for quotation, approved sources and past DLA awards.
Overview
National Stock Number record
- Open RFQs
- 1
- Next due November 18, 2026
- Last price paid
- …
- Standard price
- $15.84 per VI
- DLA's catalog price, not a price paid
- Approved sources
- 1
- One approved manufacturer listed
- Awards on record
- 43
- 2013 to 2026
- DLA demand
- –
Identification
- Item name
- Bupivacaine hydrochloride inject
- FSC / PSC
- 6505 · Drugs and biologicals
- NSG (group)
- 65 · Medical/dental/veterinary eqpt/supp
- NIIN assigned
- 27-OCT-74
- Unit
- VI
- NSN
- 6505-00-138-7347
- NIIN
- 00-138-7347
Name, end product, NIIN date and unit: DLA's Federal Logistics Information System (PUB LOG). Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
Approved suppliers
Manufacturers and suppliers DLA has qualified for this item
| Supplier | CAGE | CAGE status | Part status (RNCC / RNVC) | Supplier part # |
|---|---|---|---|---|
| PFIZER INC | 86491 | A (Active) | 3 (Design control reference) / 2 (An item-identifying number) | NDC00409-1163-18 |
Source: DLA's approved-source file published with the RFQs. CAGE and part status are FLIS's codes with DLA's wording.
Pricing and awardees
Supply contracts
1 contract DLA ordered this item under
| Award ID | Awardee | Awarding office | Ceiling | Ordering ends | Type | Multiple award | Orders | Last order |
|---|---|---|---|---|---|---|---|---|
| SPE2DX25D8022 | CARDINAL HEALTH, INC. | SPE2DX | $76,117,432 | March 6, 2035 | INDEFINITE DELIVERY / REQUIREMENTS | No | 1 | February 26, 2026 |
Source: DLA's procurement history files (the contract each order was placed under), the item's newest 2,000 award lines, joined to FPDS by the contract number. Multiple award, ordering period and ceiling are FPDS's; DLA's files do not give them.
Characteristics
Government-defined characteristics of this item (FLIS)
Hazardous and environmental
- Hazardous material (HMIC)
- Y (In hmirs)
Product characteristics
| Code | Requirement | Description |
|---|---|---|
| AKJA | Active medicament medicinal strength | PERCENTAGE, W/V BUPIVACAINE HYDROCHLORIDE ACTIVE INGREDIENT 0.50 |
| CSGS | Administration | NERVE BLOCK |
| MDES | Medical designation and grade | UNITED STATES PHARMACOPEIA |
| CXCY | Part name assigned by controlling agency | BUPIVACAINE HYDROCHLORIDE INJECTION USP 50 ML VIAL |
| AKJQ | Pharmaceutical vehicle type | AQUEOUS |
| CRLK | Primary container content quantity | MILLILITERS 50.000 |
| CQCT | Primary container type | VIAL, MULTIPLE DOSE |
| SUPP | Supplementary features | MULTIPLE-DOSE VIAL |
Additional identifiers
- II
- 0
- DEMIL
- A: No demilitarization required
- Precious metals (PMIC)
- A (Does not contain precious metal)
- Schedule B
- 3004909230 (Analgesic,cont ibuprofen,its salts,oral suspension)
- PINC
- 0035513
- Criticality (CRIT CD)
- X
- On FedMall
- Yes
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP).
Major organizational entity (MOE) rules
How each service or agency buys and manages this item
| Rule | MOE | AMC | AMSC | NIMSC | IMC | AAC | DSOR |
|---|---|---|---|---|---|---|---|
| A911 | Army (DA) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| FSGM | Air Force (DF) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| N9BL | Navy (DN) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| V542 | Veterans administration (VA) | 0Never screened | 0 |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). AMC and AMSC wording: DFARS PGI 217.7506. Hover a code for DLA's wording.
Government organizations
The services and agencies that manage or use this item
| Organization | Effective date | Unit of issue | Unit price | Qty per unit | Controlled inventory | Shelf life | Acquisition advice | Source of supply |
|---|---|---|---|---|---|---|---|---|
| Army (DA) | 01-OCT-2025 | VI | $4.75 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Air Force (DF) | 01-OCT-2025 | VI | $4.75 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Navy (DN) | 01-OCT-2025 | VI | $4.75 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| DLA (DS) | 01-OCT-2026 | VI | $15.84 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Veterans administration (VA) | 01-JUL-1988 | VI | 1 (1) | U (Unclassified) | M (24 months) | I (Direct ordering from a central contract/schedule) | JVS |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). Unit prices are DLA's standard prices (its catalog price to its customers, with DLA's surcharge), not prices DLA paid.
Packaging
FLIS packaging data of this item
FLIS packaging
- Level A
- Z (Special requirement)
- Level B
- Z (Special requirement)
- Unit container
- ZZ (Special requirement)
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP).
DIBBS RFQs
Recent DLA requests for quotation for this item on DIBBS, newest first: 1 open now
| Solicitation | NSN | Item name | Qty | Unit | Std. price | Last price | Est. value | Set-aside | Tech docs | Posted | Return by |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPE2DP27T0300DIBBS only | 6505-00-138-7347 | Bupivacaine hydrochloride inject | 13 | VI | $15.84 per VI | … | … | No set-aside | No | November 12, 2026 | November 18, 20264 days left |
| SPE2DP27T0237DIBBS only | 6505-00-138-7347 | Bupivacaine hydrochloride inject | 2 | VI | $15.84 per VI | … | … | No set-aside | No | November 4, 2026 | November 10, 2026Closed |
| SPE2DP27T0203DIBBS only | 6505-00-138-7347 | Bupivacaine hydrochloride inject | 2 | VI | $15.84 per VI | … | … | No set-aside | No | October 29, 2026 | November 4, 2026Closed |
| SPE2DP27T0151DIBBS only | 6505-00-138-7347 | Bupivacaine hydrochloride inject | 6 | VI | $15.84 per VI | … | … | No set-aside | No | October 25, 2026 | November 2, 2026Closed |
| SPE2DP26T5336DIBBS only | 6505-00-138-7347 | Bupivacaine hydrochloride inject | 5 | VI | $15.84 per VI | … | … | No set-aside | November 11, 2026First seen | October 5, 2026Closed | |
| SPE2DP26T2098DIBBS only | 6505-00-138-7347 | Bupivacaine hydrochloride inject | 4 | VI | $15.84 per VI | … | … | No set-aside | November 3, 2026First seen | March 10, 2026Closed | |
| SPE2DP26T2252DIBBS only | 6505-00-138-7347 | Bupivacaine hydrochloride inject | 1 | VI | $15.84 per VI | … | … | No set-aside | November 3, 2026First seen | March 23, 2026Closed | |
| SPE2DP26T2383DIBBS only | 6505-00-138-7347 | Bupivacaine hydrochloride inject | 3 | VI | $15.84 per VI | … | … | No set-aside | November 3, 2026First seen | March 30, 2026Closed | |
| SPE2DP26T3759DIBBS only | 6505-00-138-7347 | Bupivacaine hydrochloride inject | 3 | VI | $15.84 per VI | … | … | No set-aside | November 3, 2026First seen | June 15, 2026Closed | |
| SPE2DP26T3824DIBBS only | 6505-00-138-7347 | Bupivacaine hydrochloride inject | 1 | VI | $15.84 per VI | … | … | No set-aside | November 3, 2026First seen | June 22, 2026Closed | |
| SPE2DP26T4017DIBBS only | 6505-00-138-7347 | Bupivacaine hydrochloride inject | 1 | VI | $15.84 per VI | … | … | No set-aside | November 3, 2026First seen | July 13, 2026Closed | |
| SPE2DP26T4160DIBBS only | 6505-00-138-7347 | Bupivacaine hydrochloride inject | 10 | VI | $15.84 per VI | … | … | No set-aside | November 3, 2026First seen | July 22, 2026Closed | |
| SPE2DP26T4268DIBBS only | 6505-00-138-7347 | Bupivacaine hydrochloride inject | 12 | VI | $15.84 per VI | … | … | No set-aside | November 3, 2026First seen | July 29, 2026Closed | |
| SPE2DP26T4522DIBBS only | 6505-00-138-7347 | Bupivacaine hydrochloride inject | 3 | VI | $15.84 per VI | … | … | No set-aside | November 3, 2026First seen | August 12, 2026Closed | |
| SPE2DP26T4664DIBBS only | 6505-00-138-7347 | Bupivacaine hydrochloride inject | 1 | VI | $15.84 per VI | … | … | No set-aside | November 3, 2026First seen | August 24, 2026Closed | |
| SPE2DP26T4725DIBBS only | 6505-00-138-7347 | Bupivacaine hydrochloride inject | 6 | VI | $15.84 per VI | … | … | No set-aside | November 3, 2026First seen | August 31, 2026Closed | |
| SPE2DP26T5194DIBBS only | 6505-00-138-7347 | Bupivacaine hydrochloride inject | 2 | VI | $15.84 per VI | … | … | No set-aside | November 3, 2026First seen | September 28, 2026Closed |
Showing 1 to 10 of 17 results
→ These RFQs in the DIBBS list
“First seen”: an RFQ from DIBBS's file of all open RFQs, which gives no issue date. Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
DLA forecast
DLA's purchase forecast for the next 24 months, and its lead time
DLA's own figures
- Lead time
- administrative 15 days, production 120 days (135 in all)
Source: DLA's monthly files in its FOIA reading room: the 24-month demand forecast (what DLA expects to buy, not a commitment) and the ALT/PLT file (administrative lead time: requirement to award; production lead time: award to delivery).
DLA award history
43 award lines since 2013, 3 winning CAGEs
| Winner | Awards | Last award |
|---|---|---|
| 00E55Cardinal Health, Inc. | 21 | February 26, 2026 |
| 3W8H0MR UNLIMITED, LLC | 13 | November 4, 2026 |
| 1UNB0DMS PHARMACEUTICAL GROUP INC | 9 | September 17, 2020 |
| Year | Awards | Winning CAGEs |
|---|---|---|
| 2026 | 11 | 2 |
| 2025 | 6 | 2 |
| 2024 | 13 | 1 |
| 2023 | 2 | 2 |
| 2020 | 9 | 1 |
| 2013 | 2 | 1 |
Source: DLA's award history files (its FOIA reading room: every DLA award line since 2013, refreshed monthly), plus the past awards listed in this item's RFQ documents that those files lack. Counts are award lines, not dollars; surplus buys are left out.
DLA awards for this item
25 awards from the item's award history, in FPDS
| Rank | Vendor | Obligated | |
|---|---|---|---|
| 1 | MR UNLIMITED, LLC | $939 | 12 |
| 2 | CARDINAL HEALTH, INC. | $827 | 19 |
| 3 | DMS PHARMACEUTICAL GROUP INC | $90 | 3 |
| Contract | Awarded | Awardee | Obligated |
|---|---|---|---|
| SPE2DP26V0854From the item's award history | August 3, 2026 | MR UNLIMITED, LLC | $33 |
| SPE2DP26V0831From the item's award history | July 14, 2026 | MR UNLIMITED, LLC | $33 |
| SPE2DP26V0818From the item's award history | July 6, 2026 | MR UNLIMITED, LLC | $22 |
| SPE2DP26V0746From the item's award history | May 22, 2026 | MR UNLIMITED, LLC | $115 |
| SPE2DP26V0610From the item's award history | April 10, 2026 | MR UNLIMITED, LLC | $22 |
| SPE2D926F3048From the item's award history | February 26, 2026 | CARDINAL HEALTH, INC. | $163 |
| SPE2DP26V0419From the item's award history | February 10, 2026 | MR UNLIMITED, LLC | $167 |
| SPE2DP26V0408From the item's award history | February 6, 2026 | MR UNLIMITED, LLC | $66 |
| SPE2DP26V0394From the item's award history | February 2, 2026 | MR UNLIMITED, LLC | $84 |
| SPE2DP26V0337From the item's award history | January 21, 2026 | MR UNLIMITED, LLC | $11 |
| SPE2DP26V0069From the item's award history | October 14, 2025 | MR UNLIMITED, LLC | $11 |
| SPE2D925F4664From the item's award history | September 29, 2025 | CARDINAL HEALTH, INC. | $0 |
| SPE2D925F4631From the item's award history | September 26, 2025 | CARDINAL HEALTH, INC. | $0 |
| SPE2DP25V3763From the item's award history | September 25, 2025 | MR UNLIMITED, LLC | $200 |
| SPE2D925F3031From the item's award history | June 17, 2025 | CARDINAL HEALTH, INC. | $41 |
| SPE2D925F1574From the item's award history | February 24, 2025 | CARDINAL HEALTH, INC. | $68 |
| SPE2D924F4079From the item's award history | July 26, 2024 | CARDINAL HEALTH, INC. | $6 |
| SPE2D924F4119From the item's award history | July 26, 2024 | CARDINAL HEALTH, INC. | $3 |
| SPE2D924F3769From the item's award history | July 2, 2024 | CARDINAL HEALTH, INC. | $68 |
| SPE2D924F3639From the item's award history | June 24, 2024 | CARDINAL HEALTH, INC. | $130 |
| SPE2D924F3645From the item's award history | June 24, 2024 | CARDINAL HEALTH, INC. | $130 |
| SPE2D924F2402From the item's award history | April 2, 2024 | CARDINAL HEALTH, INC. | $26 |
| SPE2D924F2409From the item's award history | April 2, 2024 | CARDINAL HEALTH, INC. | $26 |
| SPE2D924F2426From the item's award history | April 2, 2024 | CARDINAL HEALTH, INC. | $3 |
| SPE2D924F2066From the item's award history | March 13, 2024 | CARDINAL HEALTH, INC. | $6 |
Showing 1 to 10 of 25 results
Source: DLA award notices on SAM.gov for solicitations that included this item (DLA posts them above $25,000), and the contracts of this item's past DLA awards (DLA's award history files and the RFQs' procurement history), joined to FPDS by contract number (an order under a long-term contract by the order and its contract). Amounts are FPDS obligations; DIBBS order totals are not shown. Department of Defense actions appear in FPDS about 90 days after they are signed.